Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
benzodiazepine
|
| gptkbp:ATCCode |
N05BA03
|
| gptkbp:brand |
Azepamid
Nobrium Rudotel |
| gptkbp:CASNumber |
2898-12-6
|
| gptkbp:category |
recreational drug
sedative prodrug anticonvulsant muscle relaxant hypnotic lactam chlorobenzene derivative |
| gptkbp:chemicalFormula |
C16H15ClN2
|
| gptkbp:contraindication |
gptkb:myasthenia_gravis
severe respiratory insufficiency sleep apnea syndrome severe hepatic insufficiency |
| gptkbp:discoveredBy |
1965
|
| gptkbp:eliminationHalfLife |
36–150 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Medazepam
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
GABA-A receptor positive allosteric modulator
|
| gptkbp:meltingPoint |
104–105 °C
|
| gptkbp:metabolism |
gptkb:diazepam
gptkb:oxazepam gptkb:temazepam nordazepam |
| gptkbp:molecularWeight |
270.76 g/mol
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:PubChem_CID |
4167
4023 1201242 DB01581 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
confusion
muscle weakness drowsiness ataxia dependence |
| gptkbp:synonym |
7-chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine
|
| gptkbp:UNII |
U7A1V1S8G3
|
| gptkbp:usedFor |
insomnia
anxiety disorders muscle spasms |
| gptkbp:bfsParent |
gptkb:N05BA
|
| gptkbp:bfsLayer |
7
|